Advertisement

European Journal of Clinical Microbiology

, Volume 6, Issue 4, pp 378–385 | Cite as

In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories

  • European Study Group on Antibiotic Resistance
Articles

Abstract

The in vitro susceptibilities to gentamicin, tobramycin, amikacin and netilmicin were determined by a standardized microdilution method in unsupplemented Mueller-Hinton broth using blood and urine isolates from hospitalized patients in 29 laboratories in 12 European countries. The distribution of bacteria was similar in each laboratorys,Escherichia coli and staphylococci predominating. While resistance rates varied between laboratories (e.g., rates of 1.1–34% were reported for gentamicin), they were consistently higher in southern Europe for all four antibiotics. Production of aminoglycoside-modifying enzymes was observed among resistant strains, ANT(2′), AAC(3)-V and AAC(6')-II predominating in gram-negative bacilli and APH(2)′ + AAC(6')-I in staphylococci.

Keywords

Escherichia Coli Internal Medicine European Country Gentamicin Aminoglycoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moellering, R. C., Weinstein, C., Kunz, L. J., Poitras, J. W.: Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. American Journal of Medicine 1977, 62: 873–881.PubMedGoogle Scholar
  2. 2.
    Guerrant, R. L., Strasbaugh, L. J., Wengel, R. P., Hamory, B. H., Sande, M. A.: Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli. American Journal of Medicine 1977, 62: 894–901.PubMedGoogle Scholar
  3. 3.
    Betts, R. F., Valenti, W. M., Chapman, S. W., Chonmaitree, T., Mowrer, G., Pincus, P., Messner, M., Robertson, R.: Five year surveillance of aminoglycoside usage in a university hospital. Annuals of Internal Medicine 1984, 100: 219–222.Google Scholar
  4. 4.
    Gerding, D. W., Larson, T. A.: Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. American Journal of Medicine 1985, 79, Supplement 1A: 1–7.Google Scholar
  5. 5.
    Williams, R. J., Lindridge, M. A., Said, A. A., Livermore, D. M., Williams, J. D.: National survey of antibiotic resistance inPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1984, 14: 9–16.Google Scholar
  6. 6.
    Bengtsson, S., Beinander, S., Brorson, J. E., Dornbusch, K., Forsgren, A., Haltender, H., Henning, C., Holm, S., Malmborg, A. S., Nilsson, L.: In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980–1984. Scandinavian Journal of Infectious Diseases 1986, 18: 257–263.PubMedGoogle Scholar
  7. 7.
    Davies, J., Smith, D. I.: Plasmid-determined resistance to antimicrobial agents. Annual Review of Microbiology 1978, 32: 469–518.PubMedGoogle Scholar
  8. 8.
    Miller, G. H., Sabatelli, F. J., Hare, R. S., Waitz, J. A.: Survey of aminoglycoside resistance patterns. Development Industrial Microbiology 1980, 21: 91–104.Google Scholar
  9. 9.
    Shannon, K. P., Phillips, I.: Detection of aminoglycoside-modifying strains of bacteria. In: Russel, A. D., Quesnal, L. B. (ed.): Antibiotics: assessment of antimicrobial activity and resistance. Academic Press, London, 1983, p. 183–198.Google Scholar
  10. 10.
    Davies, J.: Resistance to aminoglycosides: mechanisms and frequency. Reviews of Infectious Diseases 1983, 5, Supplement 2: 261–266.Google Scholar
  11. 11.
    The Swedish Reference Group for Antibiotics: A revised system for antibiotic sensitivity testing. Scandinavian Journal of Infectious Diseases 1981, 13: 148–152.Google Scholar
  12. 12.
    van de Klindert, J. A. M., Vhiegenthart, J. S., van Doom, E., Bengaerts, G. P. A., Molendijk, L., Mouton, R. P.: A simple method for the identification of aminoglycoside-modifying enzymes. Journal of Antimicrobial Chemotherapy 1984, 14: 339–348.PubMedGoogle Scholar
  13. 13.
    Phillips, I., Shannon, K.: Aminoglycoside resistance. British Medical Bulletin 1984, 40: 28–35.PubMedGoogle Scholar
  14. 14.
    Huovinen, P., Grönroos, P., Herva, E., Katila, M. L., Klossner, M. L., Renkonen, O. V., Toivanen, P.: Aminoglycoside resistance among blood culture isolates. Journal of Clinical Microbiology 1984, 20: 65–69.PubMedGoogle Scholar
  15. 15.
    Ljungman, P., Malmborg, A. S., Nyström, B., Tillegård, A.: Bacteremia in a Swedish University Hospital. A oneyear prospective study in 1981 and a comparison with 1975–76. Infection 1984, 1: 2–6.Google Scholar
  16. 16.
    Jackson, G. G.: Antibiotic policies, practices and pressures. Journal of Antimicrobial Chemotherapy 1979, 5: 1–4.Google Scholar
  17. 17.
    McGowan, J. E. Jr.: Antimicrobial resistance in hospital organisms and its relation to antibiotic usage. Reviews of Infectious Diseases 1983, 5: 1033–1048.PubMedGoogle Scholar
  18. 18.
    Meyer, R. D., Lewis, R. P., Halter, J., White, M.: Gentamicin-resistantPseudomonas aeruginosa andSerratia marcescens in a general hospital. Lancet 1976, i: 580–583.Google Scholar
  19. 19.
    Phillips, I., King, A., Shannon, K.: Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. American Journal of Medicine 1986, 80, Supplement B: 48–55.Google Scholar
  20. 20.
    Mouton, R. P., Glerum, J. H., van Loenen, A. C.: Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens — a seven-year survey. Journal of Antimicrobial Chemotherapy 1976, 2: 9–19.PubMedGoogle Scholar
  21. 21.
    Legakis, N. J., Velonakis, A., Velonakis, E. M., Lymberopoulou, T.: Survey of aminoglycoside resistance patterns. Chemotherapy 1986, 5: 185–190.Google Scholar
  22. 22.
    Price, K. E., Kresel, P. A., Farchione, L. A., Siskin, S. B., Karpow, S. A.: Epidemiological studies of aminoglycoside resistance in the USA. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement A: 89–105.Google Scholar
  23. 23.
    Gomez-Lus, R., Rubio-Calvo, M. C., Navarro, M.: Plasmid-determined resistance to aminocyclitols in enterobacteria. Current chemotherapy and immunotherapy. In: Periti, P., Grassi, G. G. (ed.): Proceedings of the 19th International Congress of Chemotherapy, Washington DC, American Society for Microbiology, 1982, Volume 1, p. 218–219.Google Scholar
  24. 24.
    Allen, J. R., Hightower, A. W., Martin, S. M., Dixon, R. E.: Secular trends in nosocomial infections 1970–1979. American Journal of Medicine 1981, 70: 389–392.PubMedGoogle Scholar
  25. 25.
    Weinstein, R. A., Kabins, S. A., Nathan, C., Sweeney, H. M., Jaffe, H. W., Cohen, S.: Gentamicin resistant staphylococci as hospital flora: epidemiology and resistance plasmids. Journal of Infectious Diseases 1982, 145: 374–382.PubMedGoogle Scholar
  26. 26.
    Schaefler, S.:Staphylococcus epidermidis: Antibiotic resistance patterns, physiological characteristics and bacteriophage susceptibility. Applied Microbiology 1971, 22: 693–699.PubMedGoogle Scholar
  27. 27.
    Hartman, B. J., Tomasz, A.: Expression of methicillin resistance in heterogenous strains ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1986, 29: 85–92.PubMedGoogle Scholar
  28. 28.
    Legakis, N. J., Tselentis, J., Courtis, K. J., Papavassiliou, J.: Cross-resistance of clinical isolates ofPseudomonas aeruginosa to five aminoglycosides. Journal of Antimicrobial Chemotherapy 1979, 5: 489–490.Google Scholar
  29. 29.
    Bryan, L. E., Van den Elzen, H. M.: Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrobial Agents and Chemotherapy 1977, 12: 163–177.PubMedGoogle Scholar
  30. 30.
    Bryan, L. E., O'Hara, K., Wong, S.: Lipopolysaccharide changes in permeability-type aminoglycoside resistance inPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1984, 26: 250–255.PubMedGoogle Scholar
  31. 31.
    Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavia (B) 1971, Supplement 217: 3–90.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987

Authors and Affiliations

  • European Study Group on Antibiotic Resistance

There are no affiliations available

Personalised recommendations